BBRRF - Blueberries Medical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2755
-0.0085 (-2.99%)
At close: 3:44PM EDT
Stock chart is not supported by your current browser
Previous Close0.2840
Open0.2580
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2580 - 0.2919
52 Week Range0.2580 - 0.6500
Volume109,048
Avg. Volume166,811
Market Cap28.938M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire9 days ago

    Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

    TORONTO, June 11, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and.

  • GlobeNewswire15 days ago

    Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has entered into a letter agreement (the "Letter Agreement") to become a strategic supplier of medical cannabis products to Canurius UG (“Canurius”), for the sale and distribution of cannabis products in Germany with the potential for expansion into Austria, Switzerland and the Netherlands. Pursuant to the terms of the Letter Agreement, Blueberries will provide Canurius with approximately 100 litres (100 kg) of cannabis oil extract per month for an initial 12-month term.

  • GlobeNewswirelast month

    Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval for the production, sale and export of five cannabidiol ("CBD") based health and wellness products from the Instituto Nacional de Vigilancia de Medicamentos y Alimentos ("INVIMA"), the Colombian National Food and Drug Surveillance Institute.

  • GlobeNewswire2 months ago

    Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Eduardo Molinari, a former executive of Abbott Laboratories (ABT) (“Abbott”) and AbbVie Ltd. (ABBV) (“AbbVie”) as Chief Marketing Officer. Mr. Molinari will lead the development and implementation of the Company’s marketing strategies, directing these initiatives in the local and international markets.

  • GlobeNewswire2 months ago

    Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the “Agreement”) with the International Research Center on Cannabis and Mental Health (“IRCCMH” or the “Center”) for the development of medical education programs for physicians and patients in Latin America and product formulation. IRCCMH is a leading research and academic organization in the cannabis sector with extensive experience in cannabis research and education, pharmacology, product formulation and the efficacy of cannabis-based treatments. Based in New York and aligned with the Silver School of Social Work at New York University, IRCCMH is comprised of renowned scientists, educators and clinicians and was created to bridge a gap between research and clinical practice.

  • GlobeNewswire2 months ago

    Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s executive management team will attend and present at GMP Securities’ 2019 Global Cannabis Conference on April 16, 2019 at The Ritz-Carlton, Toronto. The GMP Securities’ Global Cannabis Conference will explore current investing trends, industry perspectives on consumer trends and key developments.

  • GlobeNewswire3 months ago

    Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American focused licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced the Phase 1 planning process with Argentinian state owned cannabis company Cannabis Avatara, S.E. (“Cannava”) in connection with the cooperation agreement entered into under the scope of the “Provincial Program of Promotion of the Cultivation and Production of Cannabis with Scientific, Medicinal and Therapeutic Purposes of the Province of Jujuy in Argentina” (the “Joint Venture”), through its agreement with BBV Labs Inc. as recently announced by the Company.

  • GlobeNewswire3 months ago

    Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that its common shares will commences trading on the OTCQB Market (the “OTCQB”) today under the ticker symbol “BBRRF”. OTCQB is a trading platform in the United States operated by the OTC Markets Group in New York which provides real-time quotations and market data to a broad network of broker-dealers and retail investors.

  • PR Newswire3 months ago

    FinancialBuzz.com Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City

    NEW YORK , March 22, 2019 /PRNewswire/ --  FinancialBuzz.com , a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Chief Operating ...

  • GlobeNewswire3 months ago

    Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors

    Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Fabio Valencia Cossio, a former Colombian Minister, Senator and Ambassador to Italy with extensive strategic international business experience to its board of directors. “We are honored to welcome Mr. Valencia to our board of directors and are confident that his vast experience in public policy and international business will be a valuable addition to our leadership team,” stated Christian Toro, Chief Executive Officer.